Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208266114> ?p ?o ?g. }
- W3208266114 endingPage "e1003841" @default.
- W3208266114 startingPage "e1003841" @default.
- W3208266114 abstract "As the prevalence of hypercholesterolemia is increasing in low- and middle-income countries (LMICs), detailed evidence is urgently needed to guide the response of health systems to this epidemic. This study sought to quantify unmet need for hypercholesterolemia care among adults in 35 LMICs.We pooled individual-level data from 129,040 respondents aged 15 years and older from 35 nationally representative surveys conducted between 2009 and 2018. Hypercholesterolemia care was quantified using cascade of care analyses in the pooled sample and by region, country income group, and country. Hypercholesterolemia was defined as (i) total cholesterol (TC) ≥240 mg/dL or self-reported lipid-lowering medication use and, alternatively, as (ii) low-density lipoprotein cholesterol (LDL-C) ≥160 mg/dL or self-reported lipid-lowering medication use. Stages of the care cascade for hypercholesterolemia were defined as follows: screened (prior to the survey), aware of diagnosis, treated (lifestyle advice and/or medication), and controlled (TC <200 mg/dL or LDL-C <130 mg/dL). We further estimated how age, sex, education, body mass index (BMI), current smoking, having diabetes, and having hypertension are associated with cascade progression using modified Poisson regression models with survey fixed effects. High TC prevalence was 7.1% (95% CI: 6.8% to 7.4%), and high LDL-C prevalence was 7.5% (95% CI: 7.1% to 7.9%). The cascade analysis showed that 43% (95% CI: 40% to 45%) of study participants with high TC and 47% (95% CI: 44% to 50%) with high LDL-C ever had their cholesterol measured prior to the survey. About 31% (95% CI: 29% to 33%) and 36% (95% CI: 33% to 38%) were aware of their diagnosis; 29% (95% CI: 28% to 31%) and 33% (95% CI: 31% to 36%) were treated; 7% (95% CI: 6% to 9%) and 19% (95% CI: 18% to 21%) were controlled. We found substantial heterogeneity in cascade performance across countries and higher performances in upper-middle-income countries and the Eastern Mediterranean, Europe, and Americas. Lipid screening was significantly associated with older age, female sex, higher education, higher BMI, comorbid diagnosis of diabetes, and comorbid diagnosis of hypertension. Awareness of diagnosis was significantly associated with older age, higher BMI, comorbid diagnosis of diabetes, and comorbid diagnosis of hypertension. Lastly, treatment of hypercholesterolemia was significantly associated with comorbid hypertension and diabetes, and control of lipid measures with comorbid diabetes. The main limitations of this study are a potential recall bias in self-reported information on received health services as well as diminished comparability due to varying survey years and varying lipid guideline application across country and clinical settings.Cascade performance was poor across all stages, indicating large unmet need for hypercholesterolemia care in this sample of LMICs-calling for greater policy and research attention toward this cardiovascular disease (CVD) risk factor and highlighting opportunities for improved prevention of CVD." @default.
- W3208266114 created "2021-11-08" @default.
- W3208266114 creator A5003138186 @default.
- W3208266114 creator A5011819203 @default.
- W3208266114 creator A5011942396 @default.
- W3208266114 creator A5013060225 @default.
- W3208266114 creator A5013481506 @default.
- W3208266114 creator A5015592766 @default.
- W3208266114 creator A5025277130 @default.
- W3208266114 creator A5026974867 @default.
- W3208266114 creator A5029635780 @default.
- W3208266114 creator A5035870050 @default.
- W3208266114 creator A5035945329 @default.
- W3208266114 creator A5040203369 @default.
- W3208266114 creator A5041478034 @default.
- W3208266114 creator A5042659427 @default.
- W3208266114 creator A5048211551 @default.
- W3208266114 creator A5049061957 @default.
- W3208266114 creator A5050649371 @default.
- W3208266114 creator A5056900213 @default.
- W3208266114 creator A5057245327 @default.
- W3208266114 creator A5068905738 @default.
- W3208266114 creator A5076937097 @default.
- W3208266114 creator A5082997556 @default.
- W3208266114 creator A5090105475 @default.
- W3208266114 creator A5090658395 @default.
- W3208266114 date "2021-10-25" @default.
- W3208266114 modified "2023-10-12" @default.
- W3208266114 title "Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: A cross-sectional study of nationally representative surveys" @default.
- W3208266114 cites W1601241121 @default.
- W3208266114 cites W1607804102 @default.
- W3208266114 cites W1777587551 @default.
- W3208266114 cites W1922048564 @default.
- W3208266114 cites W1971238418 @default.
- W3208266114 cites W1973055540 @default.
- W3208266114 cites W2012391424 @default.
- W3208266114 cites W2017978418 @default.
- W3208266114 cites W2032682543 @default.
- W3208266114 cites W2047787307 @default.
- W3208266114 cites W2065030731 @default.
- W3208266114 cites W2072152755 @default.
- W3208266114 cites W2086457651 @default.
- W3208266114 cites W2104930823 @default.
- W3208266114 cites W2112669742 @default.
- W3208266114 cites W2142862362 @default.
- W3208266114 cites W2156317766 @default.
- W3208266114 cites W2170895924 @default.
- W3208266114 cites W2200285648 @default.
- W3208266114 cites W2399289168 @default.
- W3208266114 cites W2475131070 @default.
- W3208266114 cites W2519634482 @default.
- W3208266114 cites W2593329094 @default.
- W3208266114 cites W2760101477 @default.
- W3208266114 cites W2760925952 @default.
- W3208266114 cites W2786306808 @default.
- W3208266114 cites W2887110189 @default.
- W3208266114 cites W2899736836 @default.
- W3208266114 cites W2911237034 @default.
- W3208266114 cites W2913933353 @default.
- W3208266114 cites W2918851286 @default.
- W3208266114 cites W2997667981 @default.
- W3208266114 cites W3093373245 @default.
- W3208266114 cites W3183857127 @default.
- W3208266114 cites W344285755 @default.
- W3208266114 cites W4254687493 @default.
- W3208266114 doi "https://doi.org/10.1371/journal.pmed.1003841" @default.
- W3208266114 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8575312" @default.
- W3208266114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34695124" @default.
- W3208266114 hasPublicationYear "2021" @default.
- W3208266114 type Work @default.
- W3208266114 sameAs 3208266114 @default.
- W3208266114 citedByCount "16" @default.
- W3208266114 countsByYear W32082661142022 @default.
- W3208266114 countsByYear W32082661142023 @default.
- W3208266114 crossrefType "journal-article" @default.
- W3208266114 hasAuthorship W3208266114A5003138186 @default.
- W3208266114 hasAuthorship W3208266114A5011819203 @default.
- W3208266114 hasAuthorship W3208266114A5011942396 @default.
- W3208266114 hasAuthorship W3208266114A5013060225 @default.
- W3208266114 hasAuthorship W3208266114A5013481506 @default.
- W3208266114 hasAuthorship W3208266114A5015592766 @default.
- W3208266114 hasAuthorship W3208266114A5025277130 @default.
- W3208266114 hasAuthorship W3208266114A5026974867 @default.
- W3208266114 hasAuthorship W3208266114A5029635780 @default.
- W3208266114 hasAuthorship W3208266114A5035870050 @default.
- W3208266114 hasAuthorship W3208266114A5035945329 @default.
- W3208266114 hasAuthorship W3208266114A5040203369 @default.
- W3208266114 hasAuthorship W3208266114A5041478034 @default.
- W3208266114 hasAuthorship W3208266114A5042659427 @default.
- W3208266114 hasAuthorship W3208266114A5048211551 @default.
- W3208266114 hasAuthorship W3208266114A5049061957 @default.
- W3208266114 hasAuthorship W3208266114A5050649371 @default.
- W3208266114 hasAuthorship W3208266114A5056900213 @default.
- W3208266114 hasAuthorship W3208266114A5057245327 @default.
- W3208266114 hasAuthorship W3208266114A5068905738 @default.
- W3208266114 hasAuthorship W3208266114A5076937097 @default.
- W3208266114 hasAuthorship W3208266114A5082997556 @default.
- W3208266114 hasAuthorship W3208266114A5090105475 @default.